ACVR1C Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-ACVR1C antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | ACVR1C |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human, mouse, rat |
| Isotype | n/a |
| Format | peptide affinity purified |
| Size | 0.1 mL |
| Concentration | n/a |
| Applications | ELISA (EIA), Western Blot (WB) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | This antibody is predicted to have no cross-reactivity to ACVR1 or ACVR1B. Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I and two type II receptors. ACVR1C, also known as ALK7, is a type I activin receptor and plays a role in cell differentiation, growth arrest and apoptosis. ACVR1C can mediate signaling by ligans such as Nodal, GDF-1/3, activin B and activin AB, all of which can also signal through the ubiquitous activin type I receptor ACVR1B (also known as ALK4). ACVR1C is a novel marker specifically expres |
| Immunogen | Immunogen Type: Peptide Immunogen Description: Raised against a 15 amino acid peptide near the amino terminus of the human ACVR1C. |
| Other Names | [Activin A receptor type IC, Activin receptor-like kinase 7, Activin receptor type 1C precursor, ACTR-IC, ACVRLK7, ALK7, ALK-7] |
| Gene, Accession # | [ACVR1C], Gene ID: 90, NCBI: NP_001096 |
| Catalog # | MBS9405999 |
| Price | $320 |
| Order / More Info | ACVR1C Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies